Literature DB >> 12668872

A novel and functional interaction between cyclophilin A and prolactin receptor.

Farhat Syed1, Michael A Rycyzyn, Liz Westgate, Charles V Clevenger.   

Abstract

Precedent data have revealed that peptidyl isomerases can modulate the function of cell-surface receptors, but no such interactions have been previously shown for the members of the cytokine receptor superfamily. We demonstrate here that a functional interaction occurs between the prolactin receptor (PRLR) and peptidyl prolyl cis/trans isomerase cyclophilin A (CypA). CypA was co-immunoprecipitated with the PRLR in vivo from the breast epithelial cell line T47D and Chinese hamster ovary transfectants overexpressing transfected human PRLR. In addition, in vitro binding assays demonstrated a direct interaction of CypA with the PRLR, in the presence or absence of cyclosporine. Co-immunoprecipitation studies also showed an association of CypA with Jak2. Functional analysis revealed that overexpression of CypA inhibited PRL-induced Rac activation, while simultaneously prolonging Jak2 phosphorylation. These proximal actions had profound downstream effects: CypA overexpression significantly enhanced the basal and PRL-stimulated expression from a beta-casein reporter construct. Hence, the interaction between CypA and the PRLR plays a differential regulatory role in the various signaling pathways leading from the PRLR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668872     DOI: 10.1385/ENDO:20:1-2:83

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  26 in total

Review 1.  Prolactin receptor signal transduction in cells of the immune system.

Authors:  C V Clevenger; D O Freier; J B Kline
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

2.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Functional characterization of the intermediate isoform of the human prolactin receptor.

Authors:  J B Kline; H Roehrs; C V Clevenger
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

4.  Mechanism of TGFbeta receptor inhibition by FKBP12.

Authors:  Y G Chen; F Liu; J Massague
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

5.  Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor.

Authors:  M Lopez-Ilasaca; C Schiene; G Küllertz; T Tradler; G Fischer; R Wetzker
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

Review 6.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

7.  Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin.

Authors:  C V Clevenger; D H Russell; P M Appasamy; M B Prystowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.

Authors:  K D O'Neal; M V Chari; C H Mcdonald; R G Cook; L Y Yu-Lee; J D Morrisett; W T Shearer
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

10.  Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling.

Authors:  Y D Wang; W I Wood
Journal:  Mol Endocrinol       Date:  1995-03
View more
  10 in total

1.  Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.

Authors:  Sonja E Volker; Shannon E Hedrick; Yvonne B Feeney; Charles V Clevenger
Journal:  Cancer Res       Date:  2018-06-29       Impact factor: 12.701

Review 2.  Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Authors:  Andrzej Galat; Jacqueline Bua
Journal:  Cell Mol Life Sci       Date:  2010-07-04       Impact factor: 9.261

3.  Isoform-specific inhibition of cyclophilins.

Authors:  Sebastian Daum; Michael Schumann; Sebastian Mathea; Tobias Aumüller; Molly A Balsley; Stephanie L Constant; Boris Féaux de Lacroix; Fabian Kruska; Manfred Braun; Cordelia Schiene-Fischer
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

Review 4.  From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics.

Authors:  Charles V Clevenger; Jiamao Zheng; Elizabeth M Jablonski; Traci L Galbaugh; Feng Fang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

Review 5.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

6.  Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B.

Authors:  Karim Bahmed; Curtis Henry; Michael Holliday; Jasmina Redzic; Madalina Ciobanu; Fengli Zhang; Colin Weekes; Robert Sclafani; James Degregori; Elan Eisenmesser
Journal:  Cancer Cell Int       Date:  2012-07-04       Impact factor: 5.722

7.  Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target.

Authors:  Koichi Watashi; Kunitada Shimotohno
Journal:  Drug Target Insights       Date:  2007-02-05

8.  Identification and comparative analysis of the peptidyl-prolyl cis/trans isomerase repertoires of H. sapiens, D. melanogaster, C. elegans, S. cerevisiae and Sz. pombe.

Authors:  Trevor J Pemberton; John E Kay
Journal:  Comp Funct Genomics       Date:  2005

Review 9.  Cyclophilin A as a target in the treatment of cytomegalovirus infections.

Authors:  Ashwaq A Abdullah; Rasedee Abdullah; Zeenathul A Nazariah; Krishnan N Balakrishnan; Faez Firdaus J Abdullah; Jamilu A Bala; Mohd-Azmi Mohd-Lila
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

10.  Orchestration of signaling by structural disorder in class 1 cytokine receptors.

Authors:  Pernille Seiffert; Katrine Bugge; Mads Nygaard; Gitte W Haxholm; Jacob H Martinsen; Martin N Pedersen; Lise Arleth; Wouter Boomsma; Birthe B Kragelund
Journal:  Cell Commun Signal       Date:  2020-08-24       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.